Literature DB >> 11737061

IL-15-induced conversion of monocytes to mature dendritic cells.

K U Saikh1, A S Khan, T Kissner, R G Ulrich.   

Abstract

IL-15 is produced by a wide variety of tissues in response to inflammatory stimuli. We examined the effect of IL-15 in supporting the maturation of monocytes to dendritic cells in ex vivo culture. IL-15 transformed CD14(+) monocytes to mature dendritic cells. These dendritic cells were similar to those obtained from monocyte cultures treated with a combination of the cytokines GM-CSF, IL-4 and TNF-alpha. The effects of IL-15 did not depend on endogenously produced GM-CSF. The IL-15-induced dendritic cells also expressed chemokines and stimulated strong allo-responses that were characteristic of mature dendritic cells. These data indicate that CD14(+) monocytes respond to IL-15 by undergoing morphological transformation and acquiring characteristic dendritic cell features that facilitate antigen-specific responses of T cells. Thus, the release of IL-15 by inflammatory stimuli may induce the conversion of monocytes to immuno-stimulatory dendritic cells to support primary immune responses against pathogens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737061      PMCID: PMC1906219          DOI: 10.1046/j.1365-2249.2001.01672.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.

Authors:  L J Zhou; T F Tedder
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 2.  Origin, maturation and antigen presenting function of dendritic cells.

Authors:  M Cella; F Sallusto; A Lanzavecchia
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

Review 3.  IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels.

Authors:  Y Tagaya; R N Bamford; A P DeFilippis; T A Waldmann
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

4.  IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice.

Authors:  I A Khan; L H Kasper
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

5.  IL-15, an immunomodulator of T cell responses in intracellular infection.

Authors:  D Jullien; P A Sieling; K Uyemura; N D Mar; T H Rea; R L Modlin
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

6.  Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes.

Authors:  D M Anderson; S Kumaki; M Ahdieh; J Bertles; M Tometsko; A Loomis; J Giri; N G Copeland; D J Gilbert; N A Jenkins
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

7.  Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.

Authors:  E Mrózek; P Anderson; M A Caligiuri
Journal:  Blood       Date:  1996-04-01       Impact factor: 22.113

8.  Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation.

Authors:  A Blauvelt; H Asada; V Klaus-Kovtun; D J Altman; D R Lucey; S I Katz
Journal:  J Invest Dermatol       Date:  1996-05       Impact factor: 8.551

9.  Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor.

Authors:  D Saunders; K Lucas; J Ismaili; L Wu; E Maraskovsky; A Dunn; K Shortman
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor.

Authors:  J G Giri; S Kumaki; M Ahdieh; D J Friend; A Loomis; K Shanebeck; R DuBose; D Cosman; L S Park; D M Anderson
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  21 in total

1.  Innate-immunity cytokines induced by very small size proteoliposomes, a Neisseria-derived immunological adjuvant.

Authors:  C Venier; M D Guthmann; L E Fernández; L Fainboim
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.

Authors:  Medhanit Bahta; George T Lountos; Beverly Dyas; Sung-Eun Kim; Robert G Ulrich; David S Waugh; Terrence R Burke
Journal:  J Med Chem       Date:  2011-03-28       Impact factor: 7.446

3.  Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity.

Authors:  Enping Hong; Ilana M Usiskin; Cristina Bergamaschi; Douglas J Hanlon; Richard L Edelson; Sune Justesen; George N Pavlakis; Richard A Flavell; Tarek M Fahmy
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

4.  Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice.

Authors:  Tiange Chen; Yajing Zhang; Zhao Wang; Jie Yang; Mingming Li; Kunlun Wang; Min Cui; Zhen F Fu; Ling Zhao; Ming Zhou
Journal:  Virol Sin       Date:  2017-08-29       Impact factor: 4.327

5.  Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression.

Authors:  Stephanie K Watkins; Bing Li; Katharine S Richardson; Kimberly Head; Nejat K Egilmez; Qun Zeng; Jill Suttles; Robert D Stout
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

6.  IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway.

Authors:  Stephan R Krutzik; Martin Hewison; Philip T Liu; Juan Antonio Robles; Steffen Stenger; John S Adams; Robert L Modlin
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.

Authors:  Sébastien Anguille; Evelien L J M Smits; Nathalie Cools; Herman Goossens; Zwi N Berneman; Vigor F I Van Tendeloo
Journal:  J Transl Med       Date:  2009-12-18       Impact factor: 5.531

8.  Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles.

Authors:  M Cristina Lebre; Sarah L Jongbloed; Sander W Tas; Tom J M Smeets; Iain B McInnes; Paul P Tak
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

9.  Optimization of protein solubilization for the analysis of the CD14 human monocyte membrane proteome using LC-MS/MS.

Authors:  Xiaoying Ye; Donald J Johann; Ramin M Hakami; Zhen Xiao; Zhaojing Meng; Robert G Ulrich; Haleem J Issaq; Timothy D Veenstra; Josip Blonder
Journal:  J Proteomics       Date:  2009-08-24       Impact factor: 4.044

Review 10.  Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.

Authors:  Sébastien Anguille; Eva Lion; Johan Van den Bergh; Heleen H Van Acker; Yannick Willemen; Evelien L Smits; Viggo F Van Tendeloo; Zwi N Berneman
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.